premium medical cannabis products for global consumers – im cannabis (imc) is one of the world's pioneering medical-grade cannabis companies, with operations in israel, across europe, and canada. over the past decade, imc has established its premium medical cannabis brand, comprising a full spectrum of products known for their quality, consistency, and purity, such as 'roma', 'tel aviv' and 'london'. in europe, imc has established a fully operational, vertically integrated medical cannabis business, spearheaded by its eu-gmp certified distribution arm in germany and augmented by strategic alliances with certified pan-eugmp certified suppliers. to this end, imc has formed strong strategic alliances within the international medical cannabis industry, aiming for a dominant position in satisfying the global demand for high-quality medical cannabis products, which both physicians and patients can rely upon. imc further intends to leverage its expertise in israel in order to bolster its res
Company profile
Ticker
IMCC
Exchange
Website
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
IMCC stock data
Latest filings (excl ownership)
6-K
IMC to transfer its Oranim Pharmacy shares back to the seller
16 Apr 24
6-K
IM Cannabis and Flora Growth Partner to Bring Vessel Cannabis Accessories to the Israeli Market
9 Apr 24
6-K
Avant and IMC Execute BLK MKTTM Trademark Licensing Agreement for the German Medical Cannabis Market
4 Apr 24
6-K
Report on Business
4 Apr 24
6-K
Current report (foreign)
1 Apr 24
20-F
2023 FY
Annual report (foreign)
28 Mar 24
6-K
Current report (foreign)
25 Mar 24
6-K
Current report (foreign)
20 Mar 24
6-K
Report on Business
6 Mar 24
6-K
Current report (foreign)
28 Feb 24
Financial summary
Quarter (USD) | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|
Revenue | ||||
Cost of revenue | ||||
Operating income | ||||
Operating margin | ||||
Net income | ||||
Net profit margin | ||||
Cash on hand | ||||
Change in cash | ||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|
Revenue | ||||
Cost of revenue | ||||
Operating income | ||||
Operating margin | ||||
Net income | ||||
Net profit margin | ||||
Cash on hand | ||||
Change in cash | ||||
Diluted EPS |
Institutional ownership, Q2 2023
42.5% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 18 |
Opened positions | 7 |
Closed positions | 1 |
Increased positions | 1 |
Reduced positions | 1 |
13F shares | Current |
---|---|
Total value | 1.19 bn |
Total shares | 5.70 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Shuster Oren | 2.86 mm | $0.00 |
Luminera Derm | 1.51 mm | $1.95 mm |
Lynwood Capital Management | 550.00 k | $504.96 mm |
Black Maple Capital Management | 404.43 k | $371.31 mm |
AdvisorShares Investments | 233.59 k | $211.75 mm |
BMO Bank of Montreal | 75.60 k | $85.59 mm |
Renaissance Technologies | 20.30 k | $19.00 k |
Citadel Advisors | 17.13 k | $15.52 mm |
VIRT Virtu Financial | 11.09 k | $10.00 k |
EMC Capital Management | 4.70 k | $498.00 k |
News
'Cannabis Seizures At Checkpoints By U.S.-Mexico Border Frustrates State-Authorized Pot Industry' - Audacy Citing AP
19 Apr 24
IM Cannabis Has Decided Not To Make Remaining Installment Payments Installments By IMC Holdings Ltd., And As Such Will Transfer The 51% Shares Held By IMC Holdings Ltd Back To The Seller
16 Apr 24
'Marijuana Companies Ask Federal Court To Set Oral Arguments On DOJ Claim That Cannabis 'Tourism' Justifies Prohibition Enforcement' - Marijuana Moment
15 Apr 24
Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session
15 Apr 24
Why Medical Properties Trust Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
15 Apr 24
Press releases
IMC to transfer its Oranim Pharmacy shares back to the seller
16 Apr 24
IM Cannabis and Flora Growth Partner to Bring Vessel Cannabis Accessories to the Israeli Market
9 Apr 24
Avant and IMC Execute BLK MKT™ Trademark Licensing Agreement for the German Medical Cannabis Market
4 Apr 24
Avant and IMC Execute BLK MKT™ Trademark Licensing Agreement for the German Medical Cannabis Market
4 Apr 24
Avant Brands Bolsters International Growth in German Cannabis Market Through Partnership with IMC
4 Apr 24